Displaying 1 - 5 of 5
  • Print
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
40 0131BE SKAZI 40MG/ML SUSP (SKH/RXP) AZITHROMYCIN AZITHROMYCIN SKAZI 15ML A 4.89 0.33 SUSPENSION 30 ML SKH S. KANT HEALTHCARE LTD RXP RX PRO INC 08121292 OTHER MACROLIDES 2022-04-01 2024-03-31 Oral 0 ANTI-INFECTIVE AGENTS
41 0131DT SKAZI 40MG/ML SUSP (SKH) AZITHROMYCIN AZITHROMYCIN SKAZI 15ML A 4.95 0.3298 ML 30 BOX SKH S. KANT HEALTHCARE LTD ATB ANSA TRADING BARBADOS LTD B 08121292 OTHER MACROLIDES 2024-06-05 2026-03-31 ORAL 0 OTHER MACROLIDES 2024-06-05
41 1931AX MYGRA 100MG TAB (SKH) SILDENAFIL (BQ) SILDENAFIL MYGRA 4'S BQ 1.39 0.3466 TAB 30 BOX SKH S. KANT HEALTHCARE LTD ATB ANSA TRADING BARBADOS LTD 241212 PHOSPHODIESTERASE INHIBITORS 2024-04-01 2026-03-31 ORAL 6 PHOSPHODIESTERASE INHIBITORS
41 5821BB SILVERKANT 1% CR (SKH) SILVER SULPHADIAZINE SILVER SULPHADIAZINE SILVERKANT 30G A 3.26 3.262 TUBE 1 BOX SKH S. KANT HEALTHCARE LTD ATB ANSA TRADING BARBADOS LTD 840492 ANTI-INFECTIVES TOPICAL MISCELLANEOUS 2024-04-01 2026-03-31 ORAL 0 ANTI-INFECTIVES TOPICAL MISCELLANEOUS
40 5821M SILVERKANT 1% CR (SKH/RXP) SILVER SULPHADIAZI SILVER SULPHADIAZINE SILVERKANT 30G A 3.21 3.21 CREAM 1 TUBE SKH S. KANT HEALTHCARE LTD RXP RX PRO INC 840492 ANTI-INFECTIVES TOPICAL MISCELLANEOUS 2022-04-01 2024-03-31 TOPICAL 0 SKIN-MUCOUS MEMBRANE PREPARATIONS